Genetic defect in phospholipase Cδ1 protects mice from obesity by regulating thermogenesis and adipogenesis

Masayuki Hirata1, Mutsumi Suzuki, Rika Ishii

  • 1Laboratory of Genome and Biosignal, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, Japan.

Diabetes
|May 28, 2011
PubMed
Abstract

Insights

Phospholipase Cδ1 (PLCδ1) deficiency in mice leads to reduced weight gain and increased metabolic rate, suggesting PLCδ1 plays a key role in obesity development. This research highlights PLCδ1

Area of Science:

  • Metabolic research
  • Obesity research
  • Molecular biology

Background:

  • Obesity is a significant risk factor for metabolic syndromes.
  • Phospholipase Cδ1 (PLCδ1) is a key enzyme in phosphoinositide turnover.
  • Gene disruption in PLCδ1 appeared to result in leanness.

Purpose of the Study:

  • To investigate the role of PLCδ1 in obesity development.
  • To determine how PLCδ1 influences weight gain, insulin sensitivity, and metabolic rate.

Main Methods:

  • Comparison of weight gain, insulin sensitivity, and metabolic rate in PLCδ1(-/-) and PLCδ1(+/-) mice on a high-fat diet.
  • Assessment of thermogenic and adipogenetic potential in PLCδ1-deficient cells (brown adipocytes, 3T3L1 cells, WAT SVF cells).

Main Results:

  • PLCδ1(-/-) mice exhibited significantly reduced weight gain and epididymal white adipose tissue (WAT) mass.
  • These mice also showed preserved insulin sensitivity and an elevated metabolic rate, including higher oxygen consumption and heat production.
  • PLCδ1 was found to negatively regulate thermogenesis and inhibit adipogenesis, with its absence promoting brown adipocyte differentiation.

Conclusions:

  • PLCδ1 plays a critical role in regulating thermogenesis and adipogenesis.
  • These functions of PLCδ1 contribute significantly to the development of obesity.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...